Deep Medicine Acquisition Corp. Rights (DMAQR)
$0.26
$-0.03
(-10.31%)
As on 31-Jan-2024 17:30EDT
Market cap
$-- Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
0.7
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
0
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Deep Medicine Acquisition Corp. Rights (DMAQR)
| -13.3 | -13.3 | -7.1 | 160.3 | -- | -- | -- |
|
BSE Sensex*
| -10.1 | -3.6 | 2.5 | -5.7 | 4.9 | 5.5 | 10.1 |
|
Company
|
2023
|
|---|---|
|
Deep Medicine Acquisition Corp. Rights (DMAQR)
| 400.0 |
|
BSE Sensex
| 18.7 |
|
BSE Sensex
| 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Deep Medicine Acquisition Corp. Rights (DMAQR)
|
0.3 | -- | 0.1 | -1.6 | -3,129.5 | -- | -- | 0.0 |
| 17.9 | -- | 8.2 | 17.5 | -38.0 | 4.4 | -- | 0.0 | |
| 10.0 | 341.7 | 0.0 | 2.3 | -- | -- | -- | 0.0 | |
| 15.8 | 685.8 | 408.6 | -156.0 | -39.9 | -14.6 | -- | 0.7 | |
| 11.7 | 869.0 | 1,798.1 | -73.6 | 3.2 | -11.5 | -- | 12.9 | |
| 53.8 | 1,855.7 | 0.0 | -21.9 | -- | -8.5 | -- | 7.5 | |
| 13.0 | 1,006.9 | 313.3 | 56.4 | 17.4 | 17.6 | 7.4 | 2.8 | |
| 22.6 | 433.1 | 43.4 | 0.1 | 3.2 | 0.2 | 2259 | 1.0 | |
| 10.5 | 326.7 | 0.0 | 7.9 | -- | 3.4 | 40.2 | 1.4 | |
| 18.5 | 688.6 | -1,011.8 | 413.8 | 16.0 | 61.2 | -- | 0.8 |
Shareholding Pattern
View DetailsAbout Deep Medicine Acquisition Corp. Rights (DMAQR)
Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It... focuses on identifying businesses in the healthcare industry. Deep Medicine Acquisition Corp. was incorporated in 2020 and is based in New York, New York. Deep Medicine Acquisition Corp. operates as subsidiary of Bright Vision Sponsor LLC. Read more
-
CEO & Chairman of the Board
Mr. Humphrey P. Polanen
-
CEO & Chairman of the Board
Mr. Humphrey P. Polanen
-
Headquarters
New York, NY
-
Website
--
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Deep Medicine Acquisition Corp. Rights (DMAQR)
What is the current share price of Deep Medicine Acquisition Corp Rights (DMAQR) Today?
The share price of Deep Medicine Acquisition Corp Rights (DMAQR) is $0.26 (NASDAQ) as of 31-Jan-2024 17:30 EDT. Deep Medicine Acquisition Corp Rights (DMAQR) has given a return of 160.26% in the last 1 years.
What is the current PB & PE ratio of Deep Medicine Acquisition Corp Rights (DMAQR)?
Since, TTM earnings of Deep Medicine Acquisition Corp Rights (DMAQR) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2023 |
-0.84 |
0.13 |
2022 |
-4.39 |
0.01 |
2021 |
-- |
-- |
2023 |
-0.84 |
0.13 |
2022 |
-4.39 |
0.01 |
What is the 52 Week High and Low of Deep Medicine Acquisition Corp Rights (DMAQR)?
The 52-week high and low of Deep Medicine Acquisition Corp Rights (DMAQR) are Rs -- and Rs -- as of 08-Sep-2026.
What is the market cap of Deep Medicine Acquisition Corp Rights (DMAQR)?
Deep Medicine Acquisition Corp Rights (DMAQR) has a market capitalisation of -- as on 12-Feb-2024. As per SEBI classification, it is a company.
Should I invest in Deep Medicine Acquisition Corp Rights (DMAQR)?
Before investing in Deep Medicine Acquisition Corp Rights (DMAQR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.